A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first‐line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin-Reference-Cited by-同舟云学术

A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first‐line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin

Published:2020-05-19 Issue:2 Volume:126 Page:292-299
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Jones Robert¹,Crabb Simon²,Chester John³⁴⁵,Elliott Tony⁶,Huddart Robert⁷,Birtle Alison⁸,Evans Linda⁹,Lester Jason⁴,Jagdev Satinder⁵,Casbard Angela¹⁰,Huang Chao¹⁰¹¹,Madden Tracie‐Ann¹⁰,Griffiths Gareth²¹⁰^ORCID

Affiliation:

1. Beatson West of Scotland Cancer Centre University of Glasgow Glasgow UK

2. Southampton Clinical Trials Unit University of Southampton Southampton UK

3. Cardiff University Cardiff UK

4. Velindre Cancer Centre Cardiff UK

5. St. James's University Hospital Leeds UK

6. Christie Hospital NHS Foundation Trust Manchester UK

7. Institute of Cancer Research Sutton UK

8. Royal Lancaster Infirmary Lancaster UK

9. Weston Park Hospital SheffieldUK

10. Centre for Trials Research Cardiff University Cardiff UK

11. Hull York Medical School University of Hull Hull UK

Funder

Cancer Research UK

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15096

Reference28 articles.

1. Cancer Research UK.Bladder Cancer statistics reports for the UK 2016. Available at:http://www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/bladder‐cancer. Accessed January 2020

2. The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection;Wong MC;Sci Rep,2018

3. Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

4. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

5. Chemotherapy for bladder cancer: a United Kingdom practice survey;Egan PVB;J Clin Oncol,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landscape of targeted therapies for advanced urothelial carcinoma;Exploration of Targeted Anti-tumor Therapy;2024-06-21

2. Why it is important for nurses to understand basic statistics;Nursing in Critical Care;2024-01

3. Traditional Chinese Medicine Targeting Sarcoma Virus Oncogene-related Diseases;Current Cancer Drug Targets;2023-11

4. Metabolic adverse events of multitarget kinase inhibitors: a systematic review;Endocrine;2023-04-17

5. Programmed cell death, redox imbalance, and cancer therapeutics;Apoptosis;2021-07-08